11/14/2024
8:07 AM | Lynx1 Capital Management LP (Filed by)
Pieris Pharmaceuticals (Subject)
| Form SC 13G/A | |
11/13/2024
3:02 PM | Pieris Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/07/2024
8:01 AM | Pieris Pharmaceuticals (Subject)
| Form 425 | |
11/07/2024
7:47 AM | Pieris Pharmaceuticals (Filer)
| Form S-4/A | |
11/06/2024
4:00 PM | Pieris Pharmaceuticals (Filer)
| Form ARS | |
11/06/2024
4:01 PM | Pieris Pharmaceuticals (Filer)
| Form DEF 14A | |
11/05/2024
4:01 PM | Pieris Pharmaceuticals (Filer)
| Form S-4/A | |
|
10/29/2024
7:45 AM | Pieris Pharmaceuticals (Filer)
| Form S-4/A | |
10/28/2024
4:18 PM | GERAGHTY JAMES A (Reporting)
Pieris Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/17/2024
7:00 AM | Pieris Pharmaceuticals (Subject)
| Form 425 | |
10/15/2024
7:30 AM | Pieris Pharmaceuticals (Filer)
| Form S-4/A | |
10/15/2024
7:00 AM | Pieris Pharmaceuticals (Subject)
| Form 425 | |
10/03/2024
7:00 AM | Pieris Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/03/2024
7:00 AM | Pieris Pharmaceuticals (Subject)
| Form 425 | |
09/23/2024
5:15 AM | Pieris Pharmaceuticals (Filer)
| Form S-4/A | |
08/12/2024
5:48 PM | ADAR1 Capital Management, LLC (Reporting)
ADAR1 Partners, LP (Reporting)
Pieris Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/09/2024
4:29 PM | Pieris Pharmaceuticals (Filer)
| Form S-4
Registration statement under Securities Act of 1933 | |
08/07/2024
1:16 PM | Dellora Investments LP (Filed by)
Pieris Pharmaceuticals (Subject)
| Form SCHEDULE 13G | |
08/01/2024
7:00 AM | ADAR1 Capital Management, LLC (Filed by)
Pieris Pharmaceuticals (Subject)
| Form SC 13G | |
07/31/2024
6:26 PM | ADAR1 Capital Management, LLC (Reporting)
ADAR1 Partners, LP (Reporting)
Pieris Pharmaceuticals (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
07/24/2024
5:40 AM | Pieris Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/24/2024
5:40 AM | Pieris Pharmaceuticals (Subject)
| Form 425 | |
07/03/2024
3:32 PM | Pieris Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/09/2024
7:00 AM | Pieris Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/18/2024
3:21 PM | Pieris Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/29/2024
4:31 PM | Pieris Pharmaceuticals (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/27/2024
7:00 AM | Pieris Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/14/2024
12:12 PM | Checkpoint Capital L.P. (Filed by)
Pieris Pharmaceuticals (Subject)
| Form SC 13G/A | |
02/14/2024
8:19 AM | Lynx1 Capital Management LP (Filed by)
Pieris Pharmaceuticals (Subject)
| Form SC 13G/A | |
02/02/2024
8:59 AM | Pieris Pharmaceuticals (Subject)
Soleus Capital Master Fund, L.P. (Filed by)
| Form SC 13G/A | |
12/21/2023
3:30 PM | Pieris Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Free PIRS Stock Alerts